Safety Requirements for Maintenance and Distribution of Transgenic Mice Susceptible to Human Viruses: The Example of Poliovirus-Susceptible Transgenic Mice
During the last few years, considerable progress has been achieved in obtaining transgenic mice containing parts of the human genome and susceptible to human viruses. The establishment of such animal models has proven to be extremely useful. Research leading to the development of improved methods for the prevention and control of serious human viral diseases is often limited by the absence of readily available animal models capable of mimicking human interactions with the viral agent. Examples of viral diseases in which efforts have been restricted by the lack of such animal models include the acquired immunodeficiency syndrome and all forms of viral hepatitis and poliomyelitis. In each case, only certain nonhuman primate species have been shown to be susceptible to infection. The nonhuman primates which are required for such experimental work are expensive to acquire and maintain, often limited in availability, or even an endangered species.
KeywordsArthritis Hepatitis Attenuation Cage Transportation
Unable to display preview. Download preview PDF.
- Abramczuk JW, Penson DS, Leonard J, Monell-Torrens E, Belcher J, Martin M, Notkins AL (1992) Transgenic mice carrying intact HIV provirus: biological effects and organization of a transgene. J Acquir Innume Defic Syndr 5: 196–203Google Scholar
- Animals Scientific Procedures Act (UKJ); Animal Welfare Act (USA); Law Concerning the Protection and Control of Animals (Japan); Tier Schutzgestetz (Germany); The UFAW Handbook on the Care and Management of Laboratory Animals (YFAW, UK); Guide for the Care and Use of Laboratory Animals (UFAW, UK); Guide for the Care and Use of Laboratory Animals (ILAR, USA); Standards Relating to the Care and Management of Experimental Animals (Prime Minister’s Office, Japan); International Guiding Principles for Biomédical Research Involving Animals (CIOMS); Laws regulating Genetic Engineering Issues in the FRG; Society for Laboratory Animal Science: Zur Planung und Structur von Versuchstierbereichen tierexperimentell tätiger Institutionen 1988; WHO/ICLAS Guidelines for the Establishment of Animal Colonies and Use of Laboratory Animals (WHO, Geneva, in preparation)Google Scholar
- Araki K, Nishimura S, Ochiya T, Okybo K, Miyazaki J, Matsubara K, Yamamura K (1991) Production and effect of infectious Dane particles in transgenic mice Jpn J Cancer Res 82: 235–239Google Scholar
- Genetic Manipulation Guidelines on Work with Transgenic Animals (Home Office, UK); Guidelines for Recombinant DNA Experiments (Ministry of Education, Science and Culture, Japan); Cornell directive on the contained use of genetically modified micro organisms (USA); Laws Regulating Genetic Engineering Issues in the FRGGoogle Scholar
- Live Animal Regulations (IATA): The UFAW Handbook on the Care and Management of Laboratory Animals (UFAW, UK): Guide for the Care and Use of Laboratory Animals (ILAR, USA); Standards Relation to the Care and Management of Experimental Animals (Prime Minister’s Office, Japan); International Guiding Principles for Biomédical Research Involving Animals (CIOMS); WHO/ICLAS Guidelines for the Establishment of Animal Colonies and Use of Laboratory Animals, Chapter 14 (WHO, Geneva, in preparation)Google Scholar
- International Guiding Principles for Biomédical Research Involving Animals, CIMS, Geneva 1985Google Scholar
- Koike S, Hohe H (1993) Poliovirus-sensitive transgenic mice as a new animal model. In: Brown F, Lewis BP (eds) Poliovirus Attenuation: Molecular Mechanisms and Practical Aspects. Dev Biol Stand Basel, Karger, 78, pp 101–107Google Scholar
- Maintenance and distribution of transgenic mice susceptible to human viruses (1993) WHO Bulletin 71: 497-502Google Scholar
- Morrey JD, Bourn SM, Bunch TD, Jackson MK, Sidwell R, Barrows L, Daynes R, Rosen CA (1991) In vivo activation of human immunodeficiency virus type 1 long terminal repeat report by UV type A(UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 65: 5045–5051PubMedGoogle Scholar
- Small JA, Bieberich C, Chotbi Z, Hess J, Scangos G, Clements JE (1989) The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. Virol63: 1891–1896Google Scholar
- WHO/ICLAS Guidelines for Maintenance of Animals (1992) WHO, GenevaGoogle Scholar